Boston Scientific (BSX) FCF conversion US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| FCF conversion, % | 52.3% | 33.3% | 49.3% | 67.2% | 71.7% | 72.3% | |||
| Changes by years, y/y, % | -23pp | -19pp | +16pp | +18pp | +5pp | +55% | |||
Boston Scientific. FCF conversion, %
Boston Scientific. FCF conversion, changes, pp
Boston Scientific (BSX) FCF conversion US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| FCF conversion, % | 80.2% | 84.9% | 76.7% | 10.7% | 92.1% | 72.3% | ||
| Changes by years, y/y, % | -1pp | +19pp | -32pp | -18pp | +12pp | |||
| Changes by quarters, q/q, % | +51pp | +5pp | -8pp | -66pp | +81pp | |||